Cytopathology Laboratory Management Workshop

The Cytopathology Laboratory Management Workshop provides essential skills for trainees, established pathologists, and laboratorians alike. Through improved laboratory management education, the cytopathology community can broaden its overall knowledge of cytology laboratory management, improve and maintain high-quality cytology laboratories operations, and strengthen the field of cytopathology at large.

Target Audience

This educational activity is designed for pathologists, fellows/residents, cytotechnologists, and other members of the cytopathology community.

Learning Objectives

  • Develop core competencies in creating, maintaining, and improving cytology laboratory operations, including specimen collection and preparation, reporting best practices, laboratory efficiency, quality metric tracking, billing and finances, compliance with CAP and CLIA regulations, leveraging LIS and EHRs, digital and telecytology, and performing validations, quality improvement projects and root cause analyses.
  • Understand the impact of mentorship and wellness on laboratory culture and performance, and best practices for managing externally facing relationships (laboratory leadership, clinical departments, clients and providers).
  • Engage in networking to foster collaborations and develop relationships within the cytopathology community and across practice areas.
Course summary
Available credit: 
  • 10.00 AMA PRA Category 1 Credit™
  • 10.00 California Credits
  • 10.00 CMLE
  • 10.00 Florida Credits
  • 10.00 Participant
Course opens: 
Course expires: 

Course Directors:
Christopher O'Conor, MD, PhD
Vanda Torous, MD

Sarah Bean, MD
W. Stephen Black-Schaffer, MD
Christine Booth, MD
Jennifer Brainard, MD
Margaret Compton, MD
Rajesh Dash, MD
Angelique Levi, MD
Emilio Madrigal, DO
Varsha Manucha, MD
Sara Monaco, MD
Christopher O'Conor, MD, PhD
Vijayalakshmi Padmanabhan, MBBS, MPH
Vanda Torous, MD
Joe Walker, MS, SCT(ASCP)
Vivian Weiss, MD, PhD
Sarah Wobker, MD, MPH

The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:
Oscar Lin, MD, PhD: Consultant – Hologic and Jansen
Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B Pitman, MD, FIAC: Consultant – Adenocyte, LLC
Donna K. Russell, MEd, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche, MD, PhD: Ad hoc advisory board panel and Consultant – Roche
Sarah Wobker, MD, MPH: Consultant - Diagnexia

The following individuals have reported no relevant financial relationships:
Susan A. Alperstein, MS, CT(ASCP), Kristen A. Atkins, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Sean A. McNair, MPH, CT(ASCP), Michelle D. Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin T. Siddiqui, MD, FIAC, MD, Michael Thrall, MD, W. Stephen Black-Schaffer, MD, Jennifer Brainard, MD, Margaret Compton, MD, Rajesh Dash, MD, Angelique Levi, MD, Emilio Madrigal, DO, Sara E. Monaco, MD, Varsha Manucha, MD, Christopher O'Conor, MD, PhD, Vijayalakshmi Padmanabhan, MBBS, MPH, Vanda Torous, MD, Joe Walker, MS, SCT(ASCP), Vivian Weiss, MD, PhD

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.

Continuing Medical Education (CME)
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process. Earn up to 10.0 Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 10.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 10.0 continuing education credits in the State of Florida and 10.0 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 10.00 AMA PRA Category 1 Credit™
  • 10.00 California Credits
  • 10.00 CMLE
  • 10.00 Florida Credits
  • 10.00 Participant


Please login or register to take this course.